Answers are grounded in this paper and cite their sources.
Background: Biallelic EIF3F variants cause a rare autosomal recessive neurodevelopmental disorder characterized by developmental delay, intellectual disability, speech impairment, and variable neurological manifestations. This review summarizes the clinical and molecular evidence to clarify genotype-phenotype relationships and identify unresolved disease mechanisms. Methods: We conducted a focused narrative review of clinical reports, variant-specific functional studies, and relevant mechanistic literature identified through targeted searches and reference screening. Results: Most clinical evidence concerns the recurrent p.(Phe232Val) variant, with only one reported compound-heterozygous individual. Developmental delay, intellectual disability, and speech impairment are prominent clinical features, whereas autism spectrum disorder (ASD), hearing loss, epilepsy, and other manifestations are variably reported. Functional studies in engineered induced pluripotent stem cells demonstrate reduced eIF3f abundance and altered translation, but the consequences for neuronal development remain unclear. Evidence from other experimental systems suggests context-dependent eIF3f functions, although their relevance to the human disorder remains unconfirmed. Conclusions: Biallelic EIF3F variants are associated with a clinically heterogeneous neurodevelopmental disorder. Integrating the available clinical and molecular evidence highlights important gaps in our understanding of genotype-phenotype relationships and disease mechanisms, underscoring the need for larger, systematically characterized patient cohorts and allele-specific neuronal models to inform future therapeutic research.
No takes yet. Share an insight, caveat, or question.
Czepiel et al. (2026) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: